Centene Corp.

Centene Corp.

CNC
Centene Corp.US flagNew York Stock Exchange
67.60
USD
+1.76
- -
33.38BMarket Cap
Centene Corp.
CNC
(New York Stock Exchange)

Recent

price

67.60

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
22.81
25.95
39.36
50.17
71.17
95.55
127.24
140.24
154.05
180.51
194.69
216.15
251.3
283.44
312.52
394.99
402.58
Revenue per Share
0.49
0.55
0.01
0.76
1.16
1.49
1.76
2.4
2.31
3.19
3.17
2.31
2.09
4.97
6.33
-13.53
-13.1
Basic EPS, GAAP
0.87
1.3
1.35
1.76
5.26
2.76
5.8
4.32
3.16
3.59
9.64
7.21
10.89
14.82
0.3
10.32
16.14
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
2.33
2.81
2.75
3.38
4.31
5.7
6.02
7.97
9.39
12.05
11.9
13.97
16.24
22.17
29.42
17.59
20.76
Book Value per Share
2.51
3.12
3.29
3.91
4.37
5.57
-0.64
2.11
4.53
9.11
-1.89
-0.98
-2.58
4.23
6.79
9.51
12.86
Tangible Book Value per Share
195
201
206
217
233
238
319
345
390
413
571
583
575
543
522
493
492
Basic Weighted Avg Shares
4,448
5,211
8,110
10,863
16,560
22,760
40,607
48,382
60,116
74,639
111,115
125,982
144,547
153,999
163,071
194,777
198,101
Sales/Revenue/Turnover
3.53
3.91
1.68
2.55
2.8
3.1
3.11
2.48
2.43
2.75
2.84
2.59
2.52
2.25
1.95
-0.16
0.01
Operating Margin (%)
52
58
66
67
89
111
278
361
495
643
1,259
1,335
1,430
1,293
1,241
1,275
1,261
Depreciation Expense
95
111
2
165
271
355
562
828
900
1,321
1,808
1,347
1,202
2,702
3,305
-6,674
-6,444
Net Income, GAAP
38.83
37.53
38.21
39.78
42.89
48.64
51.64
28.75
34.65
26.54
35.3
26.31
38.74
24.99
22.62
- -
26.68
Effective Tax Rate (%)
2.13
2.13
0.02
1.52
1.64
1.56
1.38
1.71
1.5
1.77
1.63
1.07
0.83
1.75
2.03
-3.43
-3.25
Profit Margin (%)
-108
102
177
241
51
-24
-258
-629
27
7,391
1,808
2,732
1,664
4,040
3,738
3,674
4,944
Working Capital
328
348
535
666
874
1,216
4,651
4,695
6,648
14,260
16,682
22,190
21,071
18,590
19,161
17,966
16,308
LT Debt
797
936
954
1,243
1,891
2,324
6,054
6,876
11,023
12,692
25,962
27,022
24,237
25,956
26,510
20,056
21,527
Total Equity
9.36
10.54
6.05
9.8
11.32
11.47
8.57
7.67
6.51
6.74
5.87
5.22
4.69
5.76
5.45
- -
- -
Return on Invested Capital (%)
13.91
14.87
2.7
14.33
17.33
15.71
14.09
14.5
12.61
10.87
10.57
6.75
5.2
10.5
11.71
- -
-16.61
Return on Capital (%)
23.34
21.83
0.35
25.41
31.24
30.07
34.29
35.48
28.08
30.55
30.7
18.04
13.75
25.27
24.13
-55.56
-47.95
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
38
196
63
LT Borrowings
17,545
17,351
16,308
LT Finance Leases
- -
615
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
491
492
494
Market Capitalization
17,673
20,291
16,110

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
44,062
40,370
44,989
Cash, Cash Equivalents & STI
19,237
20,320
23,741
Accounts Receivable, Net
23,109
18,105
19,426
Inventories
- -
- -
- -
Total Current Liabilities
40,630
36,696
40,045
Payables & Accruals
18,443
15,220
18,402
ST Debt
38
196
63
Deferred Revenue
656
736
953

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.27%
-4.27%
-24.35%
Free Cash Flow
359.56%
631.95%
3,203.9%
Net Income, GAAP
0.69%
-38.22%
-301.94%
Sales/Revenue/Turnover
25.48%
12%
19.44%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
40,407
39,836
42,023
40,805
163,071
2025
46,620
48,742
49,690
49,725
194,777
2026
49,944
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.17
2.16
1.37
0.57
6.33
2025
2.64
-0.51
-13.5
-2.24
-13.53
2026
3.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Centene Corporation Centene Corporation manages a leading portfolio of government-sponsored healthcare programs, including Medicaid, Medicare Advantage, Medicare Prescription Drug Plans, Health Insurance Marketplace plans under the Ambetter brand, and TRICARE; it offers services through subsidiaries such as Wellcare for Medicare products and Envolve for pharmacy benefits management, alongside correctional healthcare via Centurion. Headquartered in St. Louis, Missouri, the company operates across all 50 states, serving more than 27 million members, primarily low-income, under-insured, and uninsured individuals, with a local approach featuring community-based health plans and innovative programs focused on physical health, emotional wellness, and social determinants of health. Founded in 1984 as a nonprofit Medicaid plan, Centene Corporation went public in 2001 and has expanded through strategic acquisitions like Wellcare in recent years; in 2024, it sold Collaborative Health Systems to Astrana Health and announced the divestiture of Magellan Specialty Health to Evolent Health, while entering a new credit agreement in March 2025 to support ongoing operations amid robust revenue growth to $44.9 billion in premium and service revenues for Q3 2025.

Company News

APIChatGPT
  • Centene Stock Soars 66% YTD: Should Investors Chase the Rally?

  • Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?

  • CENTENE CORPORATION TO HOST 2026 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL

  • Can Centene's Operational Execution Keep Margin Recovery on Track?

  • CENTENE SUBSIDIARY MERIDIAN HEALTH PLAN OF ILLINOIS AWARDED ILLINOIS MEDICAID CONTRACT

  • Can Centene's Fraud Prevention Strategy Support Margin Recovery?

  • Centene: How Paperwork Disrupted An Entire Sector

  • Can Centene's Integrated Healthcare Model Support Earnings Growth?

  • Best Growth Stocks to Buy for June 29th

  • Best Growth Stocks to Buy for June 25th

  • Canada Nickel Awards Exclusive Mandate for US$600 million Investment Tax Credit Loan Facility to SB1 Markets AS

  • Health Net Providing Special Assistance to Members and Providers Affected by Palos Warehouse Fire in Los Angeles

  • Here's Why Centene (CNC) is a Strong Value Stock

  • Here Are Tuesday's Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More

  • Best Growth Stocks to Buy for June 23rd

  • CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS

  • 3 Medical Stocks to Bet on Amid Market Optimism Following SpaceX IPO

  • Here's Why Centene (CNC) is a Strong Momentum Stock

  • Weekend Morning Brew: SpaceX's Historic IPO and Major M&A Deals

  • Modesto Residents Will Gain Access to More Affordable Homes Due to $4 Million Health Net Investment